DelSiTech is excited to announce our participation in this years Oligonucleotide & mRNA Therapeutics annual meeting, held in Boston from 13-14th March, 2024.

Few areas are in more urgent need of technical solutions, than nucleic acid based therapies. DelSiTech is actively developing silica-based long-acting controlled release technologies for exactly this purpose. We are looking forwards to connecting with many of our existing partners, as well as new innovative companies in this field.

Will you be attending the conference in Boston? Let us know here if you would like to schedule a meeting with our team.